Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network

Journal of Pathology

Volumn 182, Issue 4, 1997, Pages 442-449

  Montironi, Rodolfo ^a   Diamanti, Lucilla ^a   Pomante, Roberto ^a   Thompson, Deborah ^b   Bartels, Peter H ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Bayesian belief network; diagnostic decision support system; malignancy associated changes; prostate; prostatic adenocarcinoma; prostatic intraepithelial neoplasia

Indexed keywords

ARTICLE; ARTIFICIAL NEURAL NETWORK; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ADENOCARCINOMA; BAYES THEOREM; DECISION SUPPORT TECHNIQUES; HUMANS; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 0030749524     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199708)182:4<442::AID-PATH866>3.0.CO;2-P     Document Type: Article

References (36)

1. Bartels PH, Thompson D, Weber JE. Diagnostic and prognostic decision support systems. Pathologica 1995; 87: 221-236.
2. Montironi R, Scarpelli M, Magi Galluzzi C, Pisani E. Diagnostic quantitative pathology: classification by multiple variables and multivariate analyses. Arq Patol 1991; XXIII: 29-48.
3. Bartels PH, Thompson D, Bibbo M, Weber JE. Bayesian belief networks in quantitative histopathology. Anal Quant Cytol Histol 1992; 14: 459-473.
4. Bartels PH, Thompson D, Weber JE. Expert systems in histopathology. IV. The management of uncertainty. Anal Quant Cytol Histol 1992; 14: 1-13.
5. Bibbo M, Bartels PH, Pfeifer T, Thompson D, Minimo C, Galera Davidson H. Belief networks for grading prostate lesions. Anal Quant Cytol Histol 1993; 15: 124-135.
6. Hamilton PW, Anderson N, Bartels PH, Thompson D. Expert system support in the diagnosis of breast fine-needle aspiration biopsy using Bayesian Belief Networks. J Clin Pathol 1994; 47: 329-336.
7. Montironi R, Braccischi A, Matera G, Scarpelli M, Pisani E. Quantitaton of the prostatic intra-epithelial neoplasia. Analysis of the nucleolar size, number and location. Pathol Res Pract 1991; 87: 307-314.
8. Hamilton PW, Bartels PH, Montironi R, Anderson N, Thompson D. Improved diagnostic decision making in pathology: do inference networks hold the key? J Pathol 1995; 175: 1-5.
9. Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia Development of Bayesian belief network for diagnosis and grading. Anal Quant Cytol Histol 1994; 16: 101-112.
10. Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia (PIN). Performance of Bayesian belief network for diagnosis and grading. J Pathol 1995; 177: 153-162.
11. Montironi R, Bartels PH, Hamilton PW, Thompson D. Atypical adenomatous hyperplasia (adenosis) of the prostate: development of a Bayesian belief network for its distinction from well-differentiated adenocarcinoma. Hum Pathol 1996; 27: 396-407.
12. Montironi R, Bartels PH, Thompson D, Diamanti L, Prete E. Androgen-deprived prostate adenocarcinoma. Evaluation of treatment-related changes vs. no distinctive treatment effect with a Bayesian belief network. A methodological approach. Eur Urol 1996; 30: 307-315.
13. Morawski P. Programming Bayesian belief networks. AI Expert 1989; May: 74-79.
14. Morawski P. Understanding Bayesian belief networks. AI Expert 1989: August: 44-48.
15. Pearl J. Probabilistic Reasoning in Intelligent Systems. San Mateo, CA: Morgan Kaufman Publishing, 1988.
16. Bostwick DG. Origins of prostatic carcinoma. In: Damianov I, Cohen AH, Millis SE, Young RH, eds. Progress in Reproductive and Urinary Tract Pathology. Vol. 1. 1989; 73-90.
17. Nieburgs H. Malignancy-associated cellular markers. In: Wied GL, Keebler CM, Koss LG, Patten SF, Rosenthal DL, eds. Compendium on Diagnostic Cytology, Tutorials of Cytology. 7th edn. Chicago, IL: 1992; 409-418.
18. Bibbo M, Bartels PH, Galera Davidson H, Dytch HE, Wied GL. Markers for malignancy in the nuclear texture of histologically normal tissue from patients with thyroid tumors. Anal Quant Cytol Histol 1986; 8: 168-176.
19. Bibbo M, Michelassi F, Bartels PH, et al. Karyometric marker features in normal-appearing glands adjacent to human colonie adenocarcinoma. Cancer Res 1990; 50: 147-151.
20. Burger G, Jutting U, Rodenacker K. Changes in benign cell populations in cases of cervical cancer and its precursors. Anal Quant Cytol 1981; 3: 261-271.
21. Fleischhacker M, Lee S, Spira S, Takeuchi S, Koeffler P. DNA aneuploidy in morphologically normal colons from patients with colon cancer. Mod Pathol 1995; 8: 360-365.
22. Franzin G, Grigioni WE, Dina R, Scarpa A, Zamboni G. Mucin secretion and morphological changes of the mucosa in non-neoplastic diseases of the colon. Histopathology 1983; 7: 707-718.
23. Hall TL, Castleman KR, Rosenthal DL. Canonical analysis of cells in normal and abnormal cervical smears. Anal Quant Cytol Histol 1988; 10: 161-165.
24. Haroske G, Bergander St, König R, Meyer W. Application of malignancy-associated changes of the cervical epithelium in a hierarchic classification concept. Anal Cell Pathol 1990; 2: 189-198.
25. Hutchinson ML, Isenstein LM, Martin JJ, Zahniser DJ. Measurement of subvisual changes in cervical squamous metaplastic cells for detecting abnormality. Anal Quant Cytol Histol 1992; 14: 330-334.
26. MacAulay C, Lam S, Payne PW, LeRiche JC, Palcic B. Malignancy-associated changes in bronchial epithelial cells in biopsy specimens. Anal Quant Cytol Histol 1995; 17: 55-61.
27. Montag AG, Bartels PH, Dytch HE, Lerma-Puertas E, Michelassi F, Bibbo M. Karyometric features in nuclei near colonie adenocarcinoma. Statistical analysis. Anal Quant Cytol Histol 1991; 13: 159-167.
28. Montag AG, Bartels PH, Lerma-Puertas E, Dytch HE, Leelakusolvong S, Bibbo M. Karyometric marker features in tissue adjacent to in situ cervical carcinomas. Anal Quant Cytol Histol 1989; 11: 275-280.
29. Ngoi SS, Staiano-Coico L, Godwin TA, Wong RJ, DeCosse JJ. Abnormal DNA ploidy and proliferative patterns in superficial colonie epithelium adjacent to colorectal cancer. Cancer 1990; 66: 953-959.
30. Rosenthal DL, Missirlian N, McLatchie C, Suffin S, Castleman KR. Predicting cervical epithelial disease states using subcategories of intermediate cells. Anal Quant Cytol 1983; 5: 217.
31. Susnik B, Worth A, LeRiche J, Palcic B. Malignancy-associated changes in the breast. Changes in chromatin distribution in epithelial cells in normal-appearing tissue adjacent to carcinoma. Anal Quant Cytol Histol 1995; 17: 62-68.
32. Wersto RP, Greenebaum E, Deitch D, Kersbergen K, Koss LG. Deoxyribonucleic acid ploidy and cell cycle events in benign colonie epithelium peripheral to carcinoma. Lab Invest 1988; 58: 218-225.
33. Wied GL, Bartels PH, Bibbo M, Sychra JJ. Cytomorphometric markers for uterine cancer in intermediate cells. Anal Quant Cytol 1980; 2: 257-263.
34. Sherman AB, Koss LG, Morphometry of benign urothelial cells in the presence of cancer. Anal Quant Cytol 1983; 5: 221 A.
35. Mariani-Costantini R, Theillet C, Hutzell P, Merlo G, Schlom J, Callahan R. In situ detection of c-myc mRNA in adenocarcinomas, adenomas, and mucosa of human colon. J Histochem Cytochem 1989; 37: 293-298.
36. Saffos RO, Rhatigan RM. Benign (nonpolypoid) mucosal changes adjacent to carcinomas of the colon. A light microscopic study of 20 cases. Hum Pathol 1977; 8: 441-449.